Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-02-21 @ 6:36 PM
Study NCT ID:
NCT05043402
Status:
UNKNOWN
Last Update Posted:
2022-08-15
First Post:
2021-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
Sponsor:
OncXerna Theraputics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-11-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-09-07
First Submit QC Date:
None
Study First Post Date:
2021-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-12
Last Update Post Date:
2022-08-15
Last Update Post Date Type:
ACTUAL